Form 4: STERIS plc Executive Michael Tokich Reports Acquisition of Shares and Stock Options
SEC Form 4 Filing
Michael Tokich, Sr. Vice President and CFO of STERIS plc, reports the acquisition of shares and stock options, as well as adjustments to holdings in the company's 401(k) plan.
Summary
- On June 4, 2024, Michael J. Tokich, Sr. Vice President and CFO of STERIS plc, reported transactions involving the company's ordinary shares and stock options.
- Tokich acquired 3,423 ordinary shares at $0 price.
- Following the transaction, Tokich directly owns 42,930 ordinary shares, with 8,286 of these shares being restricted and lapsing over time.
- Tokich also indirectly owns 3,557 ordinary share equivalents through the STERIS Corporation 401(k) Plan as of May 31, 2024.
- Additionally, Tokich acquired an option to buy 21,720 ordinary shares at an exercise price of $251.34, which becomes exercisable in installments from June 4, 2025, to June 5, 2028.
Sentiment
Score: 5
Explanation: This is a neutral disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's prospects.
Positives
- The acquisition of shares by a company executive can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure related to insider transactions, which are common in publicly traded companies. It provides transparency into the trading activities of company executives.
Stakeholder Impact
- The disclosure provides transparency to shareholders regarding the transactions of company insiders.
Key Dates
| Date | Description |
|---|---|
| 05/31/2024 | Date for ordinary share equivalents held in STERIS Corporation 401(k) Plan. |
| 06/04/2024 | Date of transaction for ordinary shares and stock options. |
| 06/04/2024 | Date of earliest transaction. |
| 06/04/2034 | Expiration date of employee stock option. |
| 06/06/2024 | Date of signature for the report. |
| 10/01/2024 | Date when 432 restricted ordinary shares lapse. |
| 06/02/2025 | Date when 1,293, 573 and 564 restricted ordinary shares lapse. |
| 06/04/2025 | Date when 1,141 restricted ordinary shares lapse and 5,430 stock options become exercisable. |
| 10/01/2025 | Date when 144 restricted ordinary shares lapse. |
| 06/01/2026 | Date when 1,293 restricted ordinary shares lapse. |
| 06/02/2026 | Date when 564 restricted ordinary shares lapse. |
| 06/04/2026 | Date when 1,141 restricted ordinary shares lapse and 5,430 stock options become exercisable. |
| 06/04/2027 | Date when 1,141 restricted ordinary shares lapse and 5,430 stock options become exercisable. |
| 06/05/2028 | Date when 5,430 stock options become exercisable. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.